High mobility group box 1 (
HMGB1) played pathogenic role in
antineutrophil cytoplasmic antibody (
ANCA)-associated vasculitis (AAV). Recent findings demonstrated that
Toll-like receptor 9 (TLR9) was involved in B cell tolerance breaking of
autoimmune disease, including AAV. Here, we investigated the effect of
HMGB1 on TLR9 in B cells of AAV. In the present work, patients with
myeloperoxidase (MPO)-AAV in active stage were recruited. Intracellular TLR9 expression in various B cell subpopulations of the whole blood was detected by flow cytometry and the correlation with clinical data was analysed. Our results showed that intracellular TLR9 expression in B cells, memory B cells and plasmablasts correlated with erythrocyte sedimentation rate (ESR) or
C-reactive protein (CRP). In particular, TLR9 expression in plasma cells correlated with ESR, CRP, serum
creatinine, eGFR, and Birmingham
Vasculitis Activity Score. To further explore the effect of
HMGB1 on B cell, peripheral blood mononuclear cells (PBMCs) from AAV patients were isolated. After stimulated with
HMGB1, TLR9 expression in various B cell subpopulations and proliferation ratio of live B cells were analysed by flow cytometry. We found that TLR9 expression in plasma cells and the proliferation ratio of live B cells by
HMGB1 stimulation were significantly upregulated compared with the control group. Therefore, TLR9 expression in plasma cells was associated with disease activity of MPO-AAV.
HMGB1 could enhance TLR9 expression in plasma cells and B cell proliferation. These indicated a role of
HMGB1 on TLR9 in B cells in MPO-AAV, which would provide potential clues for intervention strategies.